Aldeyra Therapeutics SG&A Expense (TTM) Trends

Aldeyra Therapeutics Inc (ALDX)

5.50 +0.13 (+2.42%) USD | NASDAQ | Sep 27, 16:00

5.51 +0.01 (+0.18%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2024	10.64M
March 31, 2024	10.98M
December 31, 2023	13.34M
September 30, 2023	16.27M
June 30, 2023	16.93M
March 31, 2023	16.69M
December 31, 2022	15.37M
September 30, 2022	13.20M
June 30, 2022	12.50M
March 31, 2022	12.43M
December 31, 2021	11.28M
September 30, 2021	11.23M
June 30, 2021	10.93M
March 31, 2021	10.09M
December 31, 2020	9.986M
September 30, 2020	10.69M
June 30, 2020	11.28M
March 31, 2020	12.17M
December 31, 2019	12.15M
September 30, 2019	11.49M
June 30, 2019	11.71M
March 31, 2019	10.97M

Date	Value
December 31, 2018	9.876M
September 30, 2018	8.832M
June 30, 2018	7.242M
March 31, 2018	6.350M
December 31, 2017	6.186M
September 30, 2017	5.890M
June 30, 2017	5.811M
March 31, 2017	5.792M
December 31, 2016	5.520M
September 30, 2016	5.541M
June 30, 2016	5.406M
March 31, 2016	4.898M
December 31, 2015	4.415M
September 30, 2015	4.196M
June 30, 2015	3.707M
March 31, 2015	3.734M
December 31, 2014	3.563M
September 30, 2014	3.388M
June 30, 2014	3.116M
March 31, 2014	2.794M
December 31, 2013	2.135M
September 30, 2013	1.323M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

9.986M

Minimum

Dec 2020

16.93M

Maximum

Jun 2023

12.48M

Average

11.82M

Median

SG&A Expense (TTM) Benchmarks